Apart from a maturing regulatory environment and the expansion of healthcare coverage across the region, a number of other factors are contributing to the evolution of the MEA pharma market. Results from the second wave of a PhRMA-commisioned IQVIA market access study covering Saudi Arabia (KSA), UAE, Kuwait, Lebanon, Jordan, Egypt, Algeria, Morocco, Tunisia and South Africa (RSA).
Hecho con Visme Infographic Maker
IQVIA conducted the first wave of the study in 2018.
